Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/2009
05/20/2009DE102007054786A1 Trisubstituierte Furopyrimidine und ihre Verwendung Trisubstituted Furopyrimidine and their use
05/20/2009DE102007054653A1 Use of thiourea derivative to degrade advanced glycation end-products, Maillard-products and Amadori products and to prepare medicament to inhibit skin diseases during diabetes and to treat e.g. cataract, arthritis and Alzheimer's disease
05/20/2009CN201239400Y Pocket type gauze mask for preventing respiratory infectious disease
05/20/2009CN201239351Y Tablet capsule containing clopidogrel hydrogensulfate tablet and acetylsalicylic acid tablet
05/20/2009CN201238665Y Medical therapy shoes
05/20/2009CN201238613Y Underwear with medicament interlayer
05/20/2009CN101437944A Short interfering ribonucleic acid (siRNA) for oral administration
05/20/2009CN101437943A Antisense agents combining strongly bound base - modified oligonucleotide and artificial nuclease
05/20/2009CN101437942A Pharmaceutical compositions comprising anti-miRNA antisense oligonucleotides
05/20/2009CN101437935A Method of producing s-adenosyl-l-methionine-containing dry yeast having excellent storage stability, the product thereof and composition for oral intake
05/20/2009CN101437835A Short interference ribonucleic acids for treating allergic diseases
05/20/2009CN101437829A Bisadenosine compounds as adenosine A2A receptor agonists
05/20/2009CN101437828A MGLUR1 antagonists as therapeutic agents
05/20/2009CN101437826A Pentacyclic indole derivatives as antiviral agents
05/20/2009CN101437825A Fused heterocylic compounds and their use as mGluR5 modulators
05/20/2009CN101437824A Inhibitors of secretion of hepatitis B virus antigens for treatment of a chronic hepatitis virus
05/20/2009CN101437823A Polymorphs
05/20/2009CN101437822A Compounds and compositions as protein kinase inhibitors
05/20/2009CN101437821A Hydrochloride salts of 8-[{1-(3,5-bis-(trifluoromethyl) phenyl) -ethoxy}-methyl] -8-phenyl-1,7-diaza-spiro[4.5] decan-2-one and preparation process therefor
05/20/2009CN101437820A Heterobicyclic pyrazole compounds and methods of use
05/20/2009CN101437819A Pyridopyrazines and derivatives thereof as ALK and c-MET inhibitors
05/20/2009CN101437818A Novel dual action receptors antagonists (DARA) at the AT1 and ETA receptors
05/20/2009CN101437815A Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor
05/20/2009CN101437814A Benzazepine derivatives as monoamine reuptake inhibitors
05/20/2009CN101437813A Mglur5 modulators III
05/20/2009CN101437812A Quinoline derivatives for treating cancer
05/20/2009CN101437811A Quinoline derivatives
05/20/2009CN101437810A Quinazoline derivatives
05/20/2009CN101437809A Glycosidase inhibitors and methods of synthesizing same
05/20/2009CN101437807A Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
05/20/2009CN101437805A Phenylamino-benzoxazole substituted carboxylic acids, method for their production and use thereof as medicaments
05/20/2009CN101437804A Dibenzyl amine compounds and derivatives
05/20/2009CN101437802A 17-oxymacbecin derivatives and their use in the treatment of cancer and/or B-cell malignancies
05/20/2009CN101437799A p38 MAP kinase inhibitors
05/20/2009CN101437798A Mglur5 modulators II
05/20/2009CN101437797A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
05/20/2009CN101437796A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
05/20/2009CN101437795A Piperidine derivatives, their process for preparation, their use as therapeutic agents and pharmaceutical compositions containing them
05/20/2009CN101437794A Bicyclic tetrahydropyrrole compounds
05/20/2009CN101437793A Crystalline (3-cyano-1H-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
05/20/2009CN101437527A Hyaluronic acid binary mixture and treatment purpose thereof
05/20/2009CN101437526A Purine derivatives and methods of use thereof
05/20/2009CN101437525A Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350
05/20/2009CN101437524A Preparation of 2' ifluoro-2'- alkyl- substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
05/20/2009CN101437523A Treatment of cancer with 2-deoxygalactose
05/20/2009CN101437522A Solid oral dosage form containing an enhancer
05/20/2009CN101437521A Use of 3,5-seco-4-norcholestane derivatives for obtaining a cytoprotective medicament
05/20/2009CN101437520A Systems and methods for the delivery of corticosteroids having an increased lung deposition
05/20/2009CN101437519A Indazole compounds
05/20/2009CN101437518A Pharmaceutical compositions and uses thereof
05/20/2009CN101437517A Compositions and methods for enhancing analgesic potency of covalently bound compounds, attenuating its adverse side effects, and preventing their abuse
05/20/2009CN101437516A Treatment of diseases using nalmefene and its analogs
05/20/2009CN101437515A Application of methylpyrrolidine, analogue thereof, precursor thereof or derivant thereof for improving treatment of various pathological process participated with prophylaxis or treatment mode
05/20/2009CN101437514A Inhibidores of C-FMS cinasa
05/20/2009CN101437513A Use of imidazo[2,1-b)]-1,3,4-thiadiazole-2-sulfonamide compounds to treat neuropathic pain
05/20/2009CN101437512A Glucokinase activators
05/20/2009CN101437511A Agent for preventing liver disease
05/20/2009CN101437510A A pharmaceutical composition useful as acetyl cholinesterase inhibitors
05/20/2009CN101437509A Acidic composition
05/20/2009CN101437508A Stearidonic acid for improving cardiovascular health
05/20/2009CN101437507A Sleep inducer and stress insomnia ameliorating agent
05/20/2009CN101437506A Compounds for the treatment of metabolic disorders
05/20/2009CN101437505A Use of nordihydroguaiaretic acid derivatives in the treatment of drug resistant cancer, viral and microbial infection
05/20/2009CN101437504A Metal-containing virucidal compositions and uses
05/20/2009CN101437503A Compositions to reduce blood glucose levels and treat diabetes
05/20/2009CN101437502A Perfluocarbon gaseous transfer emulsion composition for medicament and biology, and obtaining method thereof and medicament
05/20/2009CN101437501A Prolongation of survival of an allograft by inhibiting complement activity
05/20/2009CN101437497A Stable lozenge compositions providing rapid release of nicotine
05/20/2009CN101437496A Chewing gum compositions providing rapid release of nicotine
05/20/2009CN101437494A Zero-order modified release solid dosage forms
05/20/2009CN101437414A Antimicrobial preparations
05/20/2009CN101437403A Treatment methods using triaryl methane compounds
05/20/2009CN101437399A Methods and agents for modulating an immune response
05/20/2009CN101437398A Cannabinoid receptor antagonists/inverse agonists useful fortreating obesity
05/20/2009CN101437397A Nucleotide and oligonucleotide prodrugs
05/20/2009CN101437395A Chemical compounds
05/20/2009CN101437394A Cationic antiseptic compositions and methods of use
05/20/2009CN101434661A Lichee polysaccharide, and extracting method and use thereof
05/20/2009CN101434660A Method for extracting Ganoderma lucidum polysaccharide by ultrasonic wave-microwave combination
05/20/2009CN101434647A Epitope/peptide recognized by hla-a2402-restricted ep/cam-specific ctl and use of the same
05/20/2009CN101434635A Water-soluble phenolic triterpenoid with antineoplastic activity and preparation thereof
05/20/2009CN101434631A Estra nitrate ester medicament for inhibiting angiogenesis
05/20/2009CN101434627A 2'-fluoro-4'-substituted nucleoside analogue, synthetic method and use thereof
05/20/2009CN101434625A Anoectochilus roxburghii glycosides, derivatives thereof, preparation and use
05/20/2009CN101434622A Antimony triphenyl complexes, as well as preparation method and application thereof
05/20/2009CN101434616A Organotin Schiff base coordination compound, as well as preparation method and application thereof
05/20/2009CN101434611A Nitrogen heterocyclic ring substituted antibiotic, and preparation method and use thereof
05/20/2009CN101434604A Condensed n-heterocyclic compounds and their use as CRF receptor antagonists
05/20/2009CN101434601A 2-furyl-1H-benzimidazole-4-acidamide type derivative
05/20/2009CN101434600A Curcumin piperidone analog and use thereof in anti-tumor medicament
05/20/2009CN101434596A Novel azaheterocyclic amides useful for treating pain
05/20/2009CN101434595A Antifungal agent-sulfur chromanone thiosemicarbazone compounds
05/20/2009CN101434593A Two crystal substances of baicalin, and preparations, pharmaceutical composition and uses thereof
05/20/2009CN101434592A Novel flavonoid extracted from Maackia amurensis
05/20/2009CN101434585A Amide derivatives as GK activators
05/20/2009CN101434584A Chiral oxazolidinone compound with antibacterial activity
05/20/2009CN101434580A Mesaconitine acylated product nitrous oxide, preparation and use
05/20/2009CN101434579A Fuziline esterification derivative, synthetic method and use
05/20/2009CN101434575A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/20/2009CN101434574A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
1 ... 2729 2730 2731 2732 2733 2734 2735 2736 2737 2738 2739 2740 2741 2742 2743 2744 2745 2746 2747 2748 2749 ... 7860